Interim report, First Quarter, 1 May 2021-31 July 2021.

24 August 2021 - 15:00

“New partnership with Clarivate is launched. The objective is to make it faster and easier to do data analysis powered by the combination of Qlucore Omics Explorer and Clarivate’s MetaCore™.

  • Net sales were SEK 1 659k (2 194).
  • Operating result (EBIT) amounted to SEK -4 049k (-1 730).
  • Net result for the period was SEK -4 078k (-1 766).
  • Cash flow from operations before investment activities totaled SEK -3 405k (463).
  • Earnings per share amounted to SEK -15,49 (-9,21).
    Earnings per share after dilution were SEK -15,20 (-9,21).
  • Launched partnership with Clarivate to make it faster and easier to do data analysis powered by Qlucore Omics Explorer and MetaCore™.
Provided by: MFN
Nasdaq First North GM (Sweden)
Qlucore AB
Qlucore makes it easier to analyze the huge amounts of complex data that are generated by innovations in the fields of genetics and proteomics. It is done by providing powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More